Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Carcinoma, Transitional Cell × Nivolumab × Clear all

Status

Sponsor Class

Study Type

Interventional 35 Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 13 Melanoma 11 Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lung Neoplasms 3 Stomach Neoplasms 2 Neoplasm Metastasis 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Recurrent Squamous Cell Lung Carcinoma 1 Recurrence 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Motor Activity 1 Lung Squamous Cell Carcinoma Stage IV 1 Locally Advanced Melanoma 1 Locally Advanced Gastric Cancer 1 Liver Diseases 1 Kidney Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Eunuchism 1 Esophageal Neoplasms 1 Erectile Dysfunction 1 Efficacy, Team 1 Dysplastic Nevus Syndrome 1

Interventions

atezolizumab 4 avelumab 3 erdafitinib 1 enfortumab vedotin 1 darolutamide 1 Surgical Procedures, Operative 1 Radiotherapy 1 Nivolumab 1 Mitomycin 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Histocompatibility Testing 1 High-Throughput Nucleotide Sequencing 1 Gemcitabine 1 Drug Therapy 1 Defecation 1 Cytological Techniques 1 Cystoscopy 1 Cisplatin 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06421311 2025-06-05

URADJ

Bristol-Myers Squibb

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡